Intramedullary cavity as an implant site for bioartificial pancreas: An in vivo study on diabetic canine

Transplantation

Volumn 90, Issue 6, 2010, Pages 604-611

  Yang, Kai Chiang ^a,b   Wu, Chang Chin ^a,c   Sumi, Shoichiro ^b   Kuo, Tzong Fu ^d   Lin, Sheng Chuan ^e   Lin, Feng Huei ^a,f  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b KYOTO UNIVERSITY   (Japan)

^c EN CHU KONG HOSPITAL   (Taiwan)

^d NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^e NATIONAL PINGTUNG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

^f NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

Author keywords

Bioartificial pancreas; Calcium phosphate cement; Immunoisolation; Xenotransplantation

Indexed keywords

C PEPTIDE; CALCIUM PHOSPHATE; INSULIN; GLUCOSE BLOOD LEVEL;

ALLOXAN DIABETES MELLITUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ARTIFICIAL PANCREAS; BONE RADIOGRAPHY; DIABETES MELLITUS; DOG; FEMALE; FEMUR; GLUCOSE BLOOD LEVEL; HISTOLOGY; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; INSULIN RELEASE; INSULINOMA; MALE; NONHUMAN; PRIORITY JOURNAL; XENOTRANSPLANTATION; ANIMAL; ARTIFICIAL ORGAN; BLOOD; DIABETES MELLITUS, EXPERIMENTAL; DONOR; HUMAN; METABOLISM; MOUSE; PANCREAS ISLET; PANCREAS TRANSPLANTATION; PATHOLOGY; PROCEDURES; SUPPLY AND DISTRIBUTION; UTILIZATION;

ANIMALS; ARTIFICIAL ORGANS; BLOOD GLUCOSE; C-PEPTIDE; DIABETES MELLITUS, EXPERIMENTAL; DOGS; FEMALE; HUMANS; INSULINOMA; ISLETS OF LANGERHANS; MALE; MICE; PANCREAS TRANSPLANTATION; TISSUE DONORS;

EID: 77957267597     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3181ca64d1     Document Type: Article

References (29)

1. Kudva YC, Basu A, Jenkins GD, et al. Glycemic variation and hypogly-cemia in patients with well-controlled type 1 diabetes on a multiple daily insulin injection program with use of glargine and ultralente as basal insulin. Endocr Pract 2007; 13: 244.
2. Bromberg JS, LeRoith D. Diabetes cure\Is the glass half full? N Engl J Med 2006; 335: 1372.
3. HanazakiK,Nosé Y,Brunicardi FC. Artificial endocrine pancreas.J Am Coll Surg 2001; 193: 310.
4. Ryan EA, Paty BW, Senior PA, et al. Five-year follow-up after clinical islet transplantation. Diabetes 2005; 54: 2060.
5. Merani S, Shapiro AM. Current status of pancreatic islet transplantation. Clin Sci 2006; 110: 611.
6. Ryan EA, Lakey JR, Rajotte RV, et al. Clinical outcomes and insulin secretion after islet transplantation with the Edmonton protocol. Diabetes 2001; 50: 710.
7. Vial T, Descotes J. Immunosuppressive drugs and cancer. Toxicology 2003; 185: 229.
8. MacKenzie DA, Hullett DA, Sollinger HW. Xenogeneic transplantation of porcine islets: An overview. Transplantation 2003; 76: 887.
9. Maki T, Monaco AP. Porcine islet xenotransplantation utilizing a vas-cularized bioartificial pancreas. Ann Transplant 1997; 2: 69.
10. Tonomura N, Shimizu A, Wang S, et al. Pig islet xenograft rejection in a mouse model with an established human immune system. Xenotrans-plantation 2008; 15: 129.
11. Prokop A. Bioartificial pancreas: Materials, devices, function, and limitations. Diabetes Technol Ther 2001; 3: 431.
12. Uchiyama T, Watanabe J, Ishihara K. Biocompatible polymer alloy membrane for implantable artificial pancreas. J Membr Sci 2002; 208: 39.
13. Maria-Engler SS, Mares-Guia M, Correa ML,etal. Microencapsulation and tissue engineering as an alternative treatment of diabetes. Braz J Med Biol Res 2001; 34: 691.
14. Qi Y,GuY, SakataN, et al. PVA hydrogel sheet macroencapsulation for the bioartificial pancreas. Biomaterials 2004; 25: 5885.
15. Ikeda H, Kobayashi N, Tanaka Y, et al. A newly developed bioartificial pancreas successfully controls blood glucose in totally pancreatecto-mized diabetic pigs. Tissue Eng 2006; 12: 1799.
16. Yang KC, Wu CC, Lin FH, et al. Chitosan/gelatin hydrogel asimmuno-isolative matrix for injectable bioartificial pancreas. Xenotransplanta-tion 2008; 15: 407.
17. De Groot M, Schuurs TA, Leuvenink HG, et al. Macrophage overgrowth affects neighboring nonovergrown encapsulated islets. J Surg Res 2003; 115: 235.
18. De Groot M, Schuurs TA, Van Schilfgaarde R.Causes of limited survival of microencapsulated pancreatic islet grafts. J Surg Res 2004; 121: 141.
19. Carlsson PO, Palm F, Andersson A, et al. Markedly decreased oxygen tension in transplanted rat pancreatic islets irrespective of the implantation site. Diabetes 2001; 50: 489.
20. De Vos P, Hamel AF, Tatarkiewicz K. Considerations for successful transplantationofencapsulated pancreatic islets.Diabetologia 2002; 45: 159.
21. Salazar-Bañuelos A, Wright J, Sigalet D, et al. The bone marrow as a potential receptor site for pancreatic islet grafts. Arch Med Res 2008; 39: 139.
22. Yang KC, Yang CY, Wu CC, et al. In vitro study of using calcium phosphate cement as immunoisolative device to enclose insulinoma/agarose microspheres as bioartificial pancreas. Biotechnol Bioeng 2007; 98: 1288.
23. 4. J Biomed Mater Res 2000; 51: 157.
24. Kizilel S, Garfinkel M, Opara E. The bioartificial pancreas: Progress and challenges. Diabetes Technol Ther 2005; 7: 968.
25. Anderson JM, Rodriguez A, Chang DT. Foreign body reaction to bio-material. Semin Immunol 2008; 20: 86.
26. Yuan HP, Li YB, De Bruijn JD, et al. Tissue response of calcium phosphate cement: A study in dogs. Biomaterials 2000; 21: 1283.
27. Yang KC, Wu CC, Sumi S, et al. Calcium phosphate cement chamber as an immunoisolative device for bioartificial pancreas: In vitro and preliminary in vivo study. Pancreas (in press).
28. Harrison JS, Rameshwar P, Chang V, et al. Oxygen saturation in the bone marrow of healthy volunteers. Blood 2002; 99: 394.
29. Robertson RP. Consequences on beta-cell function and reserve after long-term pancreas transplantation. Diabetes 2004; 53: 633.